| Q37501112 | A Nationwide Cross-Sectional Survey of Sleep-Related Problems in Japanese Visually Impaired Patients: Prevalence and Association with Health-Related Quality of Life |
| Q36897067 | A Pre-Screening Questionnaire to Predict Non-24-Hour Sleep-Wake Rhythm Disorder (N24HSWD) among the Blind |
| Q36774897 | A clinical approach to circadian rhythm sleep disorders |
| Q30405370 | A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. |
| Q24642414 | A three pulse phase response curve to three milligrams of melatonin in humans |
| Q42081805 | ATS Core Curriculum 2016: Part I. Adult Sleep Medicine |
| Q42775284 | Addition of a non-photic component to a light-based mathematical model of the human circadian pacemaker |
| Q28391850 | Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light |
| Q46594337 | Alertness, mood and performance rhythm disturbances associated with circadian sleep disorders in the blind |
| Q74332764 | Alterations of blood pressure and heart rate circadian rhythmic structure in non-blind patients affected by retinitis pigmentosa |
| Q48738662 | Alterations of the circadian system in Parkinson's disease patients. |
| Q43217823 | Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors |
| Q34310318 | An energy-optimal approach for entrainment of uncertain circadian oscillators |
| Q40022309 | An unusual cause of insomnia following IED-induced traumatic brain injury. |
| Q35236635 | Behavioral and psychiatric consequences of sleep-wake schedule disorders |
| Q37027833 | Blue-light-blocking intraocular lens implantation improves the sleep quality of cataract patients |
| Q24170395 | Bright light, dark and melatonin can promote circadian adaptation in night shift workers |
| Q35738325 | Caffeine does not entrain the circadian clock but improves daytime alertness in blind patients with non-24-hour rhythms |
| Q34099617 | Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin |
| Q37629676 | Chronobiological disorders: current and prevalent conditions |
| Q39676524 | Circadian Melatonin and Temperature Taus in Delayed Sleep-wake Phase Disorder and Non-24-hour Sleep-wake Rhythm Disorder Patients: An Ultradian Constant Routine Study. |
| Q28396717 | Circadian Rhythm Sleep Disorders |
| Q37728183 | Circadian Rhythms and Hormonal Homeostasis: Pathophysiological Implications |
| Q50779981 | Circadian Rhythms in Adipose Tissue Physiology. |
| Q37631780 | Circadian misalignment in mood disturbances |
| Q36945752 | Circadian rhythm connections to oxidative stress: implications for human health |
| Q34804250 | Circadian rhythm disturbances in depression |
| Q56093385 | Circadian rhythm sleep disorders |
| Q24675909 | Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review |
| Q34313513 | Circadian rhythm sleep disorders: pathophysiology and potential approaches to management |
| Q28741151 | Circadian system, sleep and endocrinology |
| Q36474519 | Circadian uses of melatonin in humans |
| Q29031212 | Clinical Aspects of Human Circadian Rhythms |
| Q36090692 | Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular S |
| Q35236745 | Clinical applications of melatonin in circadian disorders |
| Q42471499 | Clinical implications of the melatonin phase response curve |
| Q39687860 | Comparison of methods of temperature measurement in swine |
| Q24648432 | Complementary and alternative medicine for sleep disturbances in older adults |
| Q45033027 | Congenital anophthalmia: a circadian rhythm study |
| Q42805840 | Control of circadian phase by an artificial zinc finger transcription regulator |
| Q37741190 | Current evaluation and management of excessive daytime sleepiness. |
| Q39147457 | Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind. |
| Q88247211 | Diagnostic and Treatment Challenges of Sighted Non-24-Hour Sleep-Wake Disorder |
| Q47732906 | Disentangling the Role of Melatonin and its Receptor MTNR1B in Type 2 Diabetes: Still a Long Way to Go? |
| Q44236057 | Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia |
| Q28394033 | Effect of Light and Melatonin and Other Melatonin Receptor Agonists on Human Circadian Physiology |
| Q34455375 | Effect of sleep apnea on cognition and mood |
| Q32061240 | Effects of aging on the intrinsic circadian period of totally blind humans |
| Q33919266 | Effects of earplugs and eye masks on nocturnal sleep, melatonin and cortisol in a simulated intensive care unit environment |
| Q47554377 | Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial. |
| Q37807671 | Endocrine and metabolic changes during sleep |
| Q47919878 | Entraining the free-running circadian clocks of blind people. |
| Q44765058 | Eventual entrainment of the human circadian pacemaker by melatonin is independent of the circadian phase of treatment initiation: clinical implications |
| Q30428120 | Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans |
| Q83709989 | Expression and cellular localizaion of melatonin-synthesizing enzymes in rat and human salivary glands |
| Q34177698 | Hormone treatment of depression. |
| Q34280211 | Human aging and melatonin. Clinical relevance. |
| Q38116833 | Integration of biological clocks and rhythms |
| Q34109854 | Integration of human sleep-wake regulation and circadian rhythmicity |
| Q26853287 | Interactions between endocrine and circadian systems |
| Q33950309 | Intrinsic near-24-h pacemaker period determines limits of circadian entrainment to a weak synchronizer in humans |
| Q37270696 | Intrinsic period and light intensity determine the phase relationship between melatonin and sleep in humans |
| Q53421266 | Looking for light in the din: An examination of the circadian-disrupting properties of a medical intensive care unit. |
| Q28080813 | Manipulating the circadian and sleep cycles to protect against metabolic disease |
| Q38271225 | Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients |
| Q44753990 | Melatonin administration alters semen quality in normal men. |
| Q34894399 | Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. |
| Q34097173 | Melatonin agonists and insomnia |
| Q47739841 | Melatonin and circadian rhythms in autism: Case report |
| Q37141133 | Melatonin and human chronobiology |
| Q36474457 | Melatonin and human rhythms |
| Q46879877 | Melatonin entrains free-running blind people according to a physiological dose-response curve |
| Q90751155 | Melatonin for the prevention of postoperative delirium in older adults: a systematic review and meta-analysis |
| Q36040915 | Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment. |
| Q90371354 | Melatonin in type 2 diabetes mellitus and obesity |
| Q35432433 | Melatonin inhibits embryonic salivary gland branching morphogenesis by regulating both epithelial cell adhesion and morphology |
| Q40824907 | Melatonin is required for the circadian regulation of sleep |
| Q28345129 | Melatonin phase shifts human circadian rhythms in a placebo-controlled simulated night-work study |
| Q52574239 | Melatonin rhythm in children with enuresis. |
| Q60044589 | Melatonin suppression and sleepiness in children exposed to blue-enriched white LED lighting at night |
| Q92404206 | Melatonin: Countering Chaotic Time Cues |
| Q37078934 | Melatonin: a non-benzodiazepine hypnotic in an elderly blind female with dementia |
| Q36396126 | Melatonin: possible implications for the postoperative and critically ill patient |
| Q37945726 | Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors. |
| Q36654642 | Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback |
| Q58914961 | Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction |
| Q92515433 | Neuroendocrine Control of Sleep |
| Q25257183 | Neurotransmitters of the suprachiasmatic nuclei |
| Q43883843 | No evidence for a phase delay in human circadian rhythms after a single morning melatonin administration |
| Q24617618 | Non-24-Hour Disorder in Blind Individuals Revisited: Variability and the Influence of Environmental Time Cues |
| Q47349614 | Non-24-Hour Sleep–Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management. |
| Q34502179 | Non-visual ocular photoreception |
| Q36217285 | Nonphotic entrainment in humans? |
| Q34669691 | Outpatient treatment of sleep disorders in Alzheimer patients |
| Q38009370 | Pharmacotherapy of insomnia. |
| Q44238206 | Photic resetting of the human circadian pacemaker in the absence of conscious vision |
| Q35880158 | Physiological and metabolic functions of melatonin |
| Q37552532 | Physiology and pharmacology of melatonin in relation to biological rhythms |
| Q37776089 | Physiology of circadian entrainment |
| Q21144751 | Plasticity of the intrinsic period of the human circadian timing system |
| Q92898011 | Popular Herbal and Natural Remedies Used in Psychiatry |
| Q45241638 | Postoperative elevated cortisol excretion is not associated with suppression of 6-sulfatoxymelatonin excretion |
| Q24675939 | Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report |
| Q46504455 | Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia |
| Q43780989 | Pretreatment circadian period in free-running blind people may predict the phase angle of entrainment to melatonin |
| Q28387407 | Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial |
| Q47911217 | Prospective Study on Salivary Evening Melatonin and Sleep before and after Pinealectomy in Humans |
| Q24198232 | Ramelteon for insomnia |
| Q46440468 | Relative coordination to unknown "weak zeitgebers" in free-running blind individuals |
| Q42874665 | Rest-Activity Cycle and Melatonin Rhythm in Blind Free-Runners Have Similar Periods |
| Q37004418 | Role of the melatonin system in the control of sleep: therapeutic implications |
| Q34275963 | Seasonal Patterns of Invasive Pneumococcal Disease |
| Q28366058 | Seasonal variation in host susceptibility and cycles of certain infectious diseases |
| Q50575206 | Self-motion direction discrimination in the visually impaired. |
| Q24684932 | Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina |
| Q34401719 | Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment |
| Q91784560 | Sleep-Wake Disturbance Related to Ocular Disease: A Systematic Review of Phase-Shifting Pharmaceutical Therapies |
| Q35887308 | Social influences on mammalian circadian rhythms: animal and human studies |
| Q44187155 | Spontaneous central melatonin secretion and resorption kinetics of exogenous melatonin: a ventricular CSF study |
| Q38237022 | Tasimelteon (Hetlioz™): A New Melatonin Receptor Agonist for the Treatment of Non-24-Hour Sleep-Wake Disorder |
| Q40952954 | Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials |
| Q38785024 | Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals |
| Q34574347 | The circadian basis of winter depression |
| Q38219193 | The circadian timing system in clinical oncology |
| Q36272537 | The condition of insomnia: etiopathogenetic considerations and their impact on treatment practices |
| Q26738557 | The effect of lens aging and cataract surgery on circadian rhythm |
| Q34272772 | The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. |
| Q57794872 | The effects of time of day and chronotype on cognitive and physical performance in healthy volunteers |
| Q36051556 | The human pineal gland and melatonin in aging and Alzheimer's disease |
| Q28390753 | The impact of sleep and circadian disturbance on hormones and metabolism |
| Q60632179 | The relationship between melatonin and cortisol rhythms: clinical implications of melatonin therapy |
| Q35213432 | The relevance of melatonin to sports medicine and science. |
| Q37217240 | The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders |
| Q35685542 | The sleepy child |
| Q44956548 | The value of melatonin for sleep disorders occurring post-head injury: a pilot RCT. |
| Q24600160 | Therapeutics for Circadian Rhythm Sleep Disorders |
| Q34118849 | Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease |
| Q34707752 | Visual impairment and circadian rhythm disorders |
| Q37401165 | Winter Depression: Integrating mood, circadian rhythms, and the sleep/wake and light/dark cycles into a bio-psycho-social-environmental model |
| Q44611580 | Zeitgeber Hierarchy in Humans: Resetting the Circadian Phase Positions of Blind People Using Melatonin |
| Q54421567 | [Biological rhythms and human disease]. |